Nomura Holdings’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-13,434
Closed -$1.83M 1398
2024
Q4
$1.83M Buy
+13,434
New +$1.83M ﹤0.01% 637
2024
Q3
Sell
-1,700
Closed -$234K 1193
2024
Q2
$234K Buy
+1,700
New +$234K ﹤0.01% 929
2022
Q4
Sell
-9,000
Closed -$956K 1152
2022
Q3
$956K Buy
+9,000
New +$956K ﹤0.01% 595
2022
Q2
Hold
0
1568
2022
Q1
Sell
-4,500
Closed -$383K 1706
2021
Q4
$383K Buy
+4,500
New +$383K ﹤0.01% 1147
2021
Q2
Sell
-12,000
Closed -$1.17M 1768
2021
Q1
$1.17M Buy
+12,000
New +$1.17M ﹤0.01% 708
2020
Q4
Sell
-38,000
Closed -$3.65M 1183
2020
Q3
$3.65M Buy
+38,000
New +$3.65M 0.01% 327
2020
Q2
Sell
-8,771
Closed -$761K 901
2020
Q1
$761K Buy
8,771
+218
+3% +$18.9K ﹤0.01% 355
2019
Q4
$919K Sell
8,553
-21,947
-72% -$2.36M ﹤0.01% 483
2019
Q3
$2.73M Buy
30,500
+27,000
+771% +$2.41M 0.01% 318
2019
Q2
$297K Sell
3,500
-54,168
-94% -$4.6M ﹤0.01% 636
2019
Q1
$5.12M Sell
57,668
-7,998
-12% -$710K 0.02% 273
2018
Q4
$4.68M Buy
65,666
+9,479
+17% +$675K 0.02% 309
2018
Q3
$6.99M Buy
56,187
+17,148
+44% +$2.13M 0.02% 238
2018
Q2
$3.84M Sell
39,039
-2,243
-5% -$220K 0.01% 333
2018
Q1
$3.42K Buy
41,282
+25,400
+160% +$2.11K 0.01% 397
2017
Q4
$1.23M Sell
15,882
-16,000
-50% -$1.24M ﹤0.01% 605
2017
Q3
$1.95M Buy
31,882
+21,750
+215% +$1.33M ﹤0.01% 475
2017
Q2
$466K Buy
+10,132
New +$466K ﹤0.01% 855
2017
Q1
Sell
-9,031
Closed -$350K 1005
2016
Q4
$350K Sell
9,031
-39
-0.4% -$1.51K ﹤0.01% 831
2016
Q3
$461K Buy
+9,070
New +$461K ﹤0.01% 498
2013
Q3
Sell
-50,400
Closed -$672K 2405
2013
Q2
$672K Buy
+50,400
New +$672K 0.01% 1079